[Bioavailability of procainamide and disopyramide with and without concomitant administration of an antacid: aluminium phosphate (author's transl)].
D000328:Adult; D000368:Aged; D017607:Aluminum Compounds; D001682:Biological Availability; D004206:Disopyramide / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000494:pharmacology*; D011342:Procainamide / Q000378:metabolism*; D011725:Pyridines / Q000378:metabolism*
D017607:Aluminum Compounds; D010710:Phosphates; D011725:Pyridines; C012714:aluminum phosphate; D004206:Disopyramide; D011342:Procainamide
Influence du phosphate d'aluminium sur la biodisponibilité de la procaïnamide et du disopyramide.